Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor

Autor: Fava, Carmen, Rege-Cambrin, Giovanna, Dogliotti, Irene, Gottardi, Enrico, Berchialla, Paola, Di Gioacchino, Bruno, Crasto, Francesca, Lorenzatti, Roberta, Volpengo, Alessandro, Daraio, Filomena, Fantino, Cristina, Saglio, Giuseppe
Zdroj: In Clinical Lymphoma Myeloma and Leukemia August 2016 16 Supplement:S96-S100
Databáze: ScienceDirect